Healthways Inc (HWAY.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Healthways Inc reaffirms FY 2014 guidance


Wednesday, 23 Jul 2014 04:00pm EDT 

Healthways Inc:Affirms financial guidance for FY 2014.Says guidance for FY 2014 revenues remains in a range of $730 million to $760 million.Says guidance for FY 2014 adjusted net earnings per diluted share in a range of $ 0.11 -- $0.26.FY 2014 revenue of $741 million and EPS of $0.20 - Thomson Reuters I/B/E/S. 

Related Company News

Company Quote

11.89
 --
24 Jun 2016